The Galenica Group acquires 49% stake in pharmacy Bahnhof Apotheke Zurich
Tuesday, 23 July 2013, ↓ directly to download
The Galenica Group has acquired a 49% stake in the Bahnhof Apotheke Zurich, thereby expanding its network with a highly successful and strategically well-positioned pharmacy. With over 350,000 commuters and travellers passing through every day, Zurich’s main station is the most frequented place in Switzerland. In concluding this strategic partnership, the sole proprietor joins the leading player in the Swiss pharmacy market, taking a first step in future succession planning. As the majority shareholder, the current owner retains sole responsibility for managing the pharmacy.
_Founded in 1995, the Bahnhof Apotheke Zurich is the largest pharmacy in Switzerland and well known outside the canton. Open from 7 a.m. to midnight, 365 days a year, it is a readily accessible, professional source of advice and help for all healthcare questions – and not just for travellers. More than 100 employees advise customers in over 16 languages, offering a range of over 18,000 products
which include not only medications but also a wide range of complementary medicines, dermocosmetics and perfumery items.
_The 49% stake of the Galenica Group in the Bahnhof Apotheke Zurich expands its pharmacy network with the addition of a highly successful and strategically well-positioned location. Ingrid Barrage, formerly the sole shareholder, remains the majority shareholder with a 51% stake. She will continue to manage the pharmacy independently, based on her proven, successful concept. However, the conclusion of this strategic partnership is a first step towards future succession planning. The Galenica Group intends to become the majority shareholder at a later date. Until that time, Ingrid Barrage, as the majority shareholder, will retain sole responsibility for managing the pharmacy.
_The parties have agreed not to disclose the conditions of the transaction nor the financial figures of the Bahnhof Apotheke Zurich.
Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).
Thursday, 28 November 2013
Tuesday, 13 August 2013
Friday, 26 July 2013
Thursday, 11 July 2013
Wednesday, 10 July 2013
Head of Corporate Communications